Clinikally vs Hims & Hers

Side-by-side comparison of AI visibility scores, market position, and capabilities

Hims & Hers leads in AI visibility (86 vs 40)
Clinikally logo

Clinikally

EmergingHealthcare

General

Gurugram India YC S22 dermatology telemedicine at $9.9M revenue 2024 with 1.5M customers; $3.1M total ($2.6M Tribe/Goodwater/Sequoia seed Sep 2023) competing with Practo for India digital dermatology care.

AI VisibilityBeta
Overall Score
C40
Category Rank
#365 of 596
AI Consensus
82%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
39
Gemini
43

About

Clinikally is a Gurugram, India-based dermatology telemedicine and online pharmacy platform — backed by Y Combinator (S22) with $3.1 million in total funding including a $2.6 million seed in September 2023 led by Tribe Capital with Goodwater Capital, Sequoia Capital, and Rebel Fund — providing 1.5 million customers with integrated dermatological consultations, AI-assisted skin analysis, and prescription delivery for skin and hair conditions through a digital-first model that democratizes access to dermatology care across India. Founded in 2022 by Arjun Soin, Clinikally achieved $9.9 million in revenue in 2024 with a 76-person team, addressing the significant dermatology care access gap in a country where there are fewer than 10,000 dermatologists for 1.4 billion people.

Full profile
Hims & Hers logo

Hims & Hers

EmergingHealthcare

Telehealth Pharmacy

Consumer telehealth platform with Q3 2025 revenue of $599M (+49% YoY); 2.47M subscribers; 2025 guidance $2.3-2.4B; acquiring ZAVA for European expansion; GLP-1 weight loss, hair, and sexual health treatments shipped directly to subscribers.

AI VisibilityBeta
Overall Score
A86
Category Rank
#8 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
92
Gemini
83

About

Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for conditions that people historically avoided treating due to embarrassment, cost, or access barriers. The platform's core technology combines a direct-to-consumer digital health interface with an integrated pharmacy network, enabling patients to complete asynchronous or synchronous consultations with licensed clinicians and receive prescription treatments — including compounded medications — delivered directly to their homes.\n\nHims & Hers serves patients across sexual health, hair loss, mental health, dermatology, and weight management. The company's expansion into GLP-1 compounded weight loss medications has been a significant growth catalyst, capitalizing on surging consumer demand for semaglutide and tirzepatide alternatives during periods of branded drug shortages. With 2.47 million subscribers and a subscription-centric business model, the platform generates predictable recurring revenue from patients on ongoing treatment protocols. The company's 2025 acquisition of ZAVA expands its addressable market into European telehealth markets.\n\nHims & Hers reported Q3 revenue of $599 million, a 49% year-over-year increase, and issued full-year 2025 guidance of $2.3 to $2.4 billion — a scale that makes it one of the largest consumer telehealth companies in the world. The company's ability to compound subscriber growth with expanding treatment categories and international expansion through ZAVA provides multiple vectors for continued revenue acceleration. As healthcare consumerization intensifies and patients increasingly manage chronic conditions through digital-first platforms, Hims & Hers' brand recognition, integrated pharmacy infrastructure, and subscription model give it a durable position in consumer health.

Full profile

AI Visibility Head-to-Head

40
Overall Score
86
#365
Category Rank
#8
82
AI Consensus
79
stable
Trend
stable
39
ChatGPT
88
39
Perplexity
92
43
Gemini
83
46
Claude
90
41
Grok
89

Key Details

Category
General
Telehealth Pharmacy
Tier
Emerging
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Hims & Hers
Telehealth Pharmacy

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.